Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
  1. 4 Grant or award Director acquired 25,817 shares (grant or award)
  2. 4 Grant or award Director acquired 17,211 shares (grant or award)
  3. 4 Open-market buy Chief Executive Officer bought 345 shares at $4.95 ($1,708)
  4. 4 Grant or award Director acquired 14,317 shares (grant or award)
  5. 4 Grant or award Director acquired 14,130 shares (grant or award)
  6. 4 Grant or award Director acquired 13,757 shares (grant or award)
  7. 4 Grant or award Director acquired 13,944 shares (grant or award)
  8. 4 Open-market buy Chief Financial Officer bought 1,790 shares at an average $5.02 ($8,991)
  9. 4 Open-market buy Chief Executive Officer bought 400 shares at $5.03 ($2,012)
  10. 4 Open-market buy Chief Executive Officer bought 254 shares at $5.05 ($1,283)
  11. 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $5.03 ($10,065)
  12. 4 Grant or award Director acquired 1,210 shares (grant or award)
  13. 4 Grant or award Director acquired 1,045 shares (grant or award)
  14. 4 Grant or award Director acquired 715 shares (grant or award)
  15. 4 Grant or award Director acquired 880 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 2,264 shares at $5.30 ($11,999)
  17. 4 Open-market buy Chief Strategy/Mkt Officer bought 600 shares at $5.31 ($3,186)
  18. 4 Open-market buy Chief Executive Officer bought 929 shares at $5.46 ($5,069)
  19. 4 Grant or award Chief Strategy/Mkt Officer acquired 2,042 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 2,406 shares (grant or award)

Page 5 of 16 · 317 filings